Mark, just had a look at RCH, very impressive, only issues you face there is it's in indonesia,and it has had a good run so far. (consolidation or retrace possible, but not much based on quality of project)
Do you sell the spec that's treated you well (pending when you got in, but it has been doing well anyway) and take profits? Or do you sell the spec that's been punished by a major exiting.
There may very well be some short term pain still to unfold in ARR, but my take on it, is that RCH has had a decent run, and may look to consolidate before further advancing, on the other hand, ARR is getting wound into oversold territory, and a bounce back to 40,50 cents on any sort of news would be possible. Take away the selling from mquarrie yesterday, and we were in for the start of a recovery.
It comes down to time money investment mark, irrelevant of where you got on either of these, consider where they're going. What will either of them add in % from their current SP in the next 6 months? That is the answer to the question. I'll tip ARR for you, but you might have a better insight to RCH peers to say that RCH is well undervalued as well.
If you've made a profit on RCH, consider selling half of it. Thereby you maintain an interest.
It's a hard question mark, as you present two blue skies for me. Are there political risks in indonesia, why hasn't the old project been developed before if it has old non jorc drills? (i suspect low moly price).
Problem with selling ARR mark, is you sell at bottom low prices, and lose any bounce and recovery, which you'll be kicking yourself later for, esp if it comes good how we all vision it can.
Whereas selling one thats made you profits, you can always say that it looked after you, and you took something from it.
